Related Experiment Video
Updated: May 25, 2026

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
Cutaneous adverse drug reactions in children. A series of 90 cases
Aida Khaled1, Monia Kharfi, Myriam Ben Hamida
1Department of Dermatology, Charles Nicolle Hospital, Tunis, Tunisia.
Insights
Cutaneous adverse drug reactions (CADR) are common in children, with maculopapular eruptions caused by antibiotics being the most frequent. All children experienced favorable outcomes, even with severe reactions, highlighting the need for careful drug assessment.
Area of Science:
- Pediatric Dermatology
- Pharmacovigilance
- Drug Safety
Background:
- Cutaneous adverse drug reactions (CADR) are frequent in pediatric populations.
- These reactions present with diverse clinical manifestations and can be triggered by various medications.
Purpose of the Study:
- To investigate the epidemioclinical characteristics of CADR in Tunisian children.
- To identify the specific drugs responsible for these reactions in the studied pediatric cohort.
Main Methods:
- Retrospective analysis of 90 children under 16 with documented CADR over 18 years (1991-2008).
- Data collected included patient demographics, lesion types, causative drugs, onset delay, and treatment outcomes.
- Inclusion criteria required well-documented cutaneous drug reactions validated by the national pharmacovigilance center.
Main Results:
- Maculopapular eruption (MPE) was the most common reaction (57.7%), followed by acute urticaria (16.6%) and fixed drug eruption (14.4%).
- Antibiotics were the leading cause (55.5%), particularly betalactamins, followed by non-steroidal anti-inflammatory drugs (18.8%) and antiepileptics (11.1%).
- All patients achieved a favorable outcome, including those with severe cutaneous drug reactions.
Conclusions:
- Antibiotic-induced maculopapular eruptions are the predominant form of CADR in children.
- Establishing definitive drug causality is crucial, considering the prevalence of MPE in infectious conditions and frequent antibiotic use in pediatrics.
Background:
Cutaneous adverse drug reactions (CADR) are frequent in children. They have different clinical presentations and may be caused by several drugs.
Aim:
To evaluate the epidemioclinical features of cutaneous adverse drug reactions (CADR) and the different causative drugs in a Tunisian paediatric series.
Methods:
We have retrospectively included 90 children (under 16 years old) with a well documented cutaneous drug reaction, seen in the Department of Dermatology of Charles Nicolle hospital of Tunis over 18 years (1991-2008). Age, gender, duration of skin disorders, type of cutaneous lesions, incriminated drugs, delay between drug consumption and eruption, validation by the national pharmacovigilance centre, treatment and outcome were recorded.
Results:
Our patients were 6.9 year-aged (sex-ratio M/F 1.19). They had maculopapular eruption (MPE) (57.7%), acute urticaria (16.6%), fixed drug eruption (14.4%), erythema multiform (2.2%), photosensitization (1.1%) or severe cutaneous drug reactions (10%).Incriminated drugs were: Antibiotics (55.5%), non-steroidal antiinflammatory drugs (18.8%), antiepileptics (11.1%), and analgesics (5.5%). Betalactamins were the most commonly incriminated antibiotics (32 out of 50 patients; 64%). Barbiturates were the most commonly incriminated anti-epileptics (7/90 cases, 7.7%). Favourable outcome was noted in all patients, even those with severe drug reactions.
Conclusion:
MPE to antibiotics were the most common kinds of CADR in children. Drug responsibility should be based on solid criteria given the frequency of MPE of infectious origin and the frequent prescription of antibiotics in paediatric population.
Related Concept Videos
Drug Toxicity: Allergic Reactions
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Excretion
Drug Toxicity: Risk factors
Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug Dosing: Infants and Children
